CT scan administrated contrast agents effect on radiation dose calculation in treatment planning of radiotherapy

Not Applicable

• Conditions: Condition 1: Rectum cancer. Condition 2: Prostate cancer. Condition 3: Cervix cancer.; Malignant neoplasm of rectum; C53, C53.0; Malignant neoplasm of prostate; Malignant neoplasm of cervix uteri

• Registration Number: IRCT2015051922319N1
• Lead Sponsor: Vice chancellor for research, Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

Patients referred to the Radiotherapy-Oncology ward because of the rectum, prostate and cervix cancers;
Exclusion criteria: Renal diseases, Diabetes, Allergic asthma, Food and Drug allergies, Prior reactions to contrast agents and taking some drugs like Metformin

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Radiation dose. Timepoint: Before and after the intervention. Method of measurement: Dosimetry with treatment planning system.